Why the study?
Does electrophysiologic mapping and surgical excision improve survival in infants with myocardial hamartomas causing tachyarrhythmias?
Does electrophysiologic mapping and surgical excision improve survival in infants with myocardial hamartomas causing tachyarrhythmias?
Electrophysiologic mapping and surgical excision of myocardial hamartomas in infants can provide long-term cure for otherwise highly fatal tachyarrhythmias.
Answers are grounded in this paper and cite their sources.
May support mapping-guided excision for refractory infant hamartoma tachyarrhythmias; leaves open confirmation in prospective studies.
We have observed in 11 infants, aged 2 years or less, a distinct clinicopathologic lesion responsible for tachyarrhythmias that were fatal in 96% (25/26) of previously reported cases. Nine of the 11 patients, who underwent electrophysiologic mapping and surgical excision of the lesion, have survived, with follow-up periods ranging from 1 month to 6 years. The morphologic findings in these 11 patients and in the 26 cases cited in the literature are reviewed. Pathogenic considerations have included viral-induced lesion, cardiomyopathy, neoplasm, and developmental disorder of Purkinje cells. We believe this lesion to be a myocardial hamartoma. Supportive evidence includes prevalence in infants, tumorlike growth pattern without mitotic figures, and association of other developmental abnormalities. Through electrophysiologic mapping, this myocardial hamartoma is potentially accessible to surgical excision and long-term cure.
No takes yet. Share an insight, caveat, or question.
Kearney et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: